Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis.

Zan, Jincan; Ma, Jun; Man, Qian; Liu, Xingzi; Yu, Donghe; Zhang, Yuemiao; Lv, Jicheng; Zhang, Hong

Zan, Jincan; Ma, Jun; Man, Qian; Liu, Xingzi; Yu, Donghe; Zhang, Yuemiao; Lv, Jicheng; Zhang, Hong.

Afiliación

Zan J; Renal Division, Peking University First Hospital, Beijing, China.
Ma J; Peking University Institute of Nephrology, Peking University Health Science Center, Beijing, China.
Man Q; Key Laboratory of Kidney Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
Liu X; Research Units of Diagnosis and Treatment of Immune-mediate Kidney Disease, Chinese Academy of Medical Sciences, Beijing, China.
Yu D; Renal Division, Peking University First Hospital, Beijing, China.
Zhang Y; Peking University Institute of Nephrology, Peking University Health Science Center, Beijing, China.
Lv J; Key Laboratory of Kidney Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
Zhang H; Research Units of Diagnosis and Treatment of Immune-mediate Kidney Disease, Chinese Academy of Medical Sciences, Beijing, China.

Kidney Int Rep ; 7(6): 1435-1436, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35399860

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Kidney Int Rep Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google